Table of Contents

Part 1 Market Overview

• 1.1 Market Definition
• 1.2 Market Development
  • 1.2.1 Current Situation
  • 1.2.2 Aspects of COVID-19 Impact
• 1.3 By Type

Table Type of Immuno-oncology Drugs

Figure Global Immuno-oncology Drugs Market Share by Type in 2020

• 1.4 By Application

Table Application of Immuno-oncology Drugs

Figure Global Immuno-oncology Drugs Market Share by Application in 2020

• 1.5 By Region

Figure Global Immuno-oncology Drugs Market Share by Region in 2020

Figure Asia Immuno-oncology Drugs Market Share by Region in 2020

Part 2 Key Companies

• 2.1 Amgen, Inc
  • 2.1.1 Company Profile

Table Amgen, Inc Overview List

• 2.1.2 Products & Services Overview
• 2.1.3 Sales Data List

Table Immuno-oncology Drugs Business Operation of Amgen, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

• 2.2 AstraZeneca, Plc
• 2.3 Bristol-Myers Squibb
• 2.4 Celgene Corporation
• 2.5 Eli Lilly and Company
• 2.6 Merck & Co.
• 2.7 Hoffmann-La Roche AG
• 2.8 Johnson & Johnson
• 2.9 Novartis International AG
• 2.10 AbbVie, Inc.
• 2.11 Pfizer Inc.
• 2.12 Sanofi S.A.
• 2.13 EMD Serono, Inc.
• 2.14 Gilead Sciences Inc.
• 2.15 Prometheus Therapeutics & Diagnostics
• 2.16 Aduro BioTech
• 2.17 Galena Biopharma
• 2.18 Bavarian Nordic
• 2.19 Celldex Therapeutics
• 2.20 ImmunoCellular Therapeutics
• 2.21 Incyte
• 2.22 Dendreon Corporation
• 2.23 Agilent Technologies Inc.
• 2.24 Agenus Inc.
• 2.25 Enzo Biochem, Inc.
• 2.26 Lonza Group
• 2.27 Bio-Rad Laboratories, Inc.
• 2.28 Avantor, Inc.
• 2.29 Spring Bank Pharmaceuticals, Inc.
• 2.30 Ferring Pharmaceuticals

Part 3 Global Market Status and Future Forecast

• 3.1 Global Market by Region

Table Global Immuno-oncology Drugs Market by Region, 2016-2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Region in 2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Region, 2016-2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Region in 2020 (Volume)

Table Price List by Region, 2016-2020

• 3.2 Global Market by Company

Table Global Immuno-oncology Drugs Market by Company, 2016-2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Company in 2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Company, 2016-2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Company in 2020 (Volume)

Table Price List by Company, 2016-2020

• 3.3 Global Market by Type

Table Global Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Table Price List by Type, 2016-2020

• 3.4 Global Market by Application

Table Global Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Table Price List by Application, 2016-2020

• 3.5 Global Market by Forecast

Figure Global Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Global Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Part 4 Asia-Pacific Market Status and Future Forecast

• 4.1 Asia-Pacific Market by Type

Table Asia-Pacific Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Table Asia-Pacific Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Table Price List by Type, 2016-2020

• 4.2 Asia-Pacific Market by Application

Table Asia-Pacific Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Table Asia-Pacific Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Table Price List by Application, 2016-2020

• 4.3 Asia-Pacific Market by Geography
  • 4.3.1 China Market Status and Future Forecast

Figure China Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure China Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure China Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure China Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 4.3.2 Southeast Asia Market Status and Future Forecast

Figure Southeast Asia Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Southeast Asia Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Southeast Asia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Southeast Asia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 4.3.3 India Market Status and Future Forecast

Figure India Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure India Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure India Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure India Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 4.3.4 Japan Market Status and Future Forecast

Figure Japan Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Japan Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Japan Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Japan Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 4.3.5 Korea Market Status and Future Forecast

Figure Korea Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Korea Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Korea Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Korea Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 4.3.6 Oceania Market Status and Future Forecast

Figure Oceania Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Oceania Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Oceania Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Oceania Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 4.4 Asia-Pacific Market by Forecast

Figure Asia-Pacific Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Asia-Pacific Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Part 5 Europe Market Status and Future Forecast

• 5.1 Europe Market by Type

Table Europe Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Figure Europe Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Table Europe Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Figure Europe Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Table Price List by Type, 2016-2020

• 5.2 Europe Market by Application

Table Europe Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Figure Europe Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Table Europe Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Figure Europe Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Table Price List by Application, 2016-2020

• 5.3 Europe Market by Geography
  • 5.3.1 Germany Market Status and Future Forecast

Figure Germany Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Germany Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Germany Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Germany Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.2 UK Market Status and Future Forecast

Figure UK Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure UK Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure UK Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure UK Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.3 France Market Status and Future Forecast

Figure France Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure France Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure France Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure France Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.4 Italy Market Status and Future Forecast

Figure Italy Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Italy Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Italy Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Italy Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.5 Russia Market Status and Future Forecast

Figure Russia Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Russia Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Russia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Russia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.6 Spain Market Status and Future Forecast

Figure Spain Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Spain Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Spain Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Spain Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.6 Netherlands Market Status and Future Forecast

Figure Netherlands Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Netherlands Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Netherlands Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Netherlands Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.7 Turkey Market Status and Future Forecast

Figure Turkey Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Turkey Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Turkey Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Turkey Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.3.6 Switzerland Market Status and Future Forecast

Figure Switzerland Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Switzerland Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Switzerland Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Switzerland Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 5.4 Europe Market by Forecast

Figure Europe Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Europe Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Part 6 North America Market Status and Future Forecast

• 6.1 North America Market by Type

Table North America Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Figure North America Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Table North America Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Figure North America Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Table Price List by Type, 2016-2020

• 6.2 North America Market by Application

Table North America Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Figure North America Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Table North America Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Figure North America Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Table Price List by Application, 2016-2020

• 6.3 North America Market by Geography
  • 6.3.1 United States Market Status and Future Forecast

Figure United States Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure United States Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure United States Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure United States Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 6.3.2 Canada Market Status and Future Forecast

Figure Canada Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Canada Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Canada Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Canada Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 6.3.3 Mexico Market Status and Future Forecast

Figure Mexico Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Mexico Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Mexico Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Mexico Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 6.4 North America Market by Forecast

Figure North America Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure North America Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Part 7 South America Market Status and Future Forecast

• 7.1 South America Market by Type

Table South America Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Figure South America Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Table South America Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Figure South America Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Table Price List by Type, 2016-2020

• 7.2 South America Market by Application

Table South America Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Figure South America Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Table South America Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Figure South America Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Table Price List by Application, 2016-2020

• 7.3 South America Market by Geography
  • 7.3.1 Brazil Market Status and Future Forecast

Figure Brazil Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Brazil Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Brazil Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Brazil Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 7.3.2 Argentina Market Status and Future Forecast

Figure Argentina Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Argentina Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Argentina Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Argentina Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 7.3.3 Columbia Market Status and Future Forecast

Figure Columbia Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Columbia Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Columbia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Columbia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 7.3.4 Chile Market Status and Future Forecast

Figure Chile Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Chile Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Chile Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Chile Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 7.3.5 Peru Market Status and Future Forecast

Figure Peru Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Peru Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Peru Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Peru Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 7.4 South America Market by Forecast

Figure South America Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure South America Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Part 8 Middle East & Africa Market Status and Future Forecast

• 8.1 Middle East & Africa Market by Type

Table Middle East & Africa Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Figure Middle East & Africa Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Table Middle East & Africa Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Figure Middle East & Africa Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Table Price List by Type, 2016-2020

• 8.2 Middle East & Africa Market by Application

Table Middle East & Africa Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Figure Middle East & Africa Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Table Middle East & Africa Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Figure Middle East & Africa Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Table Price List by Application, 2016-2020

• 8.3 Middle East & Africa Market by Geography
  • 8.3.1 GCC Market Status and Future Forecast

Figure GCC Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure GCC Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure GCC Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure GCC Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 8.3.2 North Africa Market Status and Future Forecast

Figure North Africa Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure North Africa Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure North Africa Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure North Africa Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 8.3.3 South Africa Market Status and Future Forecast

Figure South Africa Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure South Africa Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure South Africa Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure South Africa Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

• 8.4 Middle East & Africa Market by Forecast

Figure Middle East & Africa Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Middle East & Africa Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Part 9 Market Features

• 9.1 Product Features
• 9.2 Price Features
• 9.3 Channel Features
• 9.4 Purchasing Features

Part 10 Investment Opportunity

• 10.1 Regional Investment Opportunity
• 10.2 Industry Investment Opportunity

PART 11 Coronavirus Impact

• 11.1 Impact on Industry Upstream
• 11.2 Impact on Industry Downstream
• 11.3 Impact on Industry Channels
• 11.4 Impact on Industry Competition
• 11.5 Impact on Industry Obtain Employment

Part 12 Conclusion

List of Table

Table Type of Immuno-oncology Drugs

Table Application of Immuno-oncology Drugs

Table Amgen, Inc Overview List

Table Immuno-oncology Drugs Business Operation of Amgen, Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pharma & Healthcare Business Operation of AstraZeneca, Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Business Operation of Bristol-Myers Squibb (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Volume Business Operation of Celgene Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table xxx Business Operation of Eli Lilly and Company (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table xx% Business Operation of Merck & Co. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 17 Business Operation of Hoffmann-La Roche AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 3 Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 0 Business Operation of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 2 Business Operation of AbbVie, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 1800 Business Operation of Pfizer Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 2160 Business Operation of Sanofi S.A. (Sales Revenue, Cost, Gross Margin)

Table 2810 Business Operation of EMD Serono, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table 88 Business Operation of Gilead Sciences Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Prometheus Therapeutics & Diagnostics (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Aduro BioTech (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Galena Biopharma (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Bavarian Nordic (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Celldex Therapeutics (Sales Revenue, Cost, Gross Margin)

Table Business Operation of ImmunoCellular Therapeutics (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Incyte (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Dendreon Corporation (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Agilent Technologies Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Agenus Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Enzo Biochem, Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Lonza Group (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Bio-Rad Laboratories, Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Avantor, Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Spring Bank Pharmaceuticals, Inc. (Sales Revenue, Cost, Gross Margin)

Table Business Operation of Ferring Pharmaceuticals (Sales Revenue, Cost, Gross Margin)

Table Global Immuno-oncology Drugs Market by Region, 2016-2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Region, 2016-2020 (Volume)

Table Price List by Region, 2016-2020

Table Global Immuno-oncology Drugs Market by Company, 2016-2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Company, 2016-2020 (Volume)

Table Price List by Company, 2016-2020

Table Global Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Table Price List by Type, 2016-2020

Table Global Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Table Global Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Table Price List by Application, 2016-2020

Table Asia-Pacific Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Table Asia-Pacific Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Table Price List by Type, 2016-2020

Table Asia-Pacific Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Table Asia-Pacific Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Table Price List by Application, 2016-2020

Table Europe Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Table Europe Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Table Price List by Type, 2016-2020

Table Europe Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Table Europe Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Table Price List by Application, 2016-2020

Table North America Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Table North America Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Table Price List by Type, 2016-2020

Table North America Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Table North America Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Table Price List by Application, 2016-2020

Table South America Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Table South America Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Table Price List by Type, 2016-2020

Table South America Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Table South America Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Table Price List by Application, 2016-2020

Table Middle East & Africa Immuno-oncology Drugs Market by Type, 2016-2020 (Million USD)

Table Middle East & Africa Immuno-oncology Drugs Market by Type, 2016-2020 (Volume)

Table Price List by Type, 2016-2020

Table Middle East & Africa Immuno-oncology Drugs Market by Application, 2016-2020 (Million USD)

Table Middle East & Africa Immuno-oncology Drugs Market by Application, 2016-2020 (Volume)

Table Price List by Application, 2016-2020

List of Figure

Figure Global Immuno-oncology Drugs Market Share by Type in 2020

Figure Global Immuno-oncology Drugs Market Share by Application in 2020

Figure Global Immuno-oncology Drugs Market Share by Region in 2020

Figure Asia Immuno-oncology Drugs Market Share by Region in 2020

Figure Global Immuno-oncology Drugs Market Share by Region in 2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Region in 2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Company in 2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Company in 2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Figure Global Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Figure Global Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Figure Global Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Global Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Type in 2020 (Million USD)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Type in 2020 (Volume)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Application in 2020 (Million USD)

Figure Asia-Pacific Immuno-oncology Drugs Market Share by Application in 2020 (Volume)

Figure China Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure China Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure China Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure China Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Figure Southeast Asia Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Southeast Asia Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Southeast Asia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Southeast Asia Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Figure India Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure India Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure India Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure India Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Figure Japan Immuno-oncology Drugs Market Market Status, 2016-2020 (Million USD)

Figure Japan Immuno-oncology Drugs Market Market Status, 2016-2020 (Volume)

Figure Japan Immuno-oncology Drugs Market Forecast, 2021E-2026F (Million USD)

Figure Japan Immuno-oncology Drugs Market Forecast, 2021E-2026F (Volume)

Figure Korea Immuno-oncology Drugs Market Market Status, 2

Summary
The report forecast global Immuno-oncology Drugs market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.
The report offers detailed coverage of Immuno-oncology Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Immuno-oncology Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
First, this report covers the present status and the future prospects of the global Immuno-oncology Drugs market for 2016-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
At the same time, we classify Immuno-oncology Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Finally, the report provides detailed profile and data information analysis of leading Immuno-oncology Drugs company.
Key Content of Chapters as follows (Including and can be customized) :
Part 1:
Market Overview, Development, and Segment by Type, Application & Region
Part 2:
Company information, Sales, Cost, Margin etc.
Part 3:
Global Market by company, Type, Application & Geography
Part 4:
Asia-Pacific Market by Type, Application & Geography
Part 5:
Europe Market by Type, Application & Geography
Part 6:
North America Market by Type, Application & Geography
Part 7:
South America Market by Type, Application & Geography
Part 8:
Middle East & Africa Market by Type, Application & Geography
Part 9:
Market Features
Part 10:
Investment Opportunity
Part 11:
Conclusion
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
Key Companies
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie, Inc.
Pfizer Inc.
Sanofi S.A.
EMD Serono, Inc.
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Dendreon Corporation
Agilent Technologies Inc.
Agenus Inc.
Enzo Biochem, Inc.
Lonza Group
Bio-Rad Laboratories, Inc.
Avantor, Inc.
Spring Bank Pharmaceuticals, Inc.
Ferring Pharmaceuticals
Market by Type
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Oncolytic Virus
Others
Market by Application
Hospitals
Clinics
Ambulatory Surgical Centers